article thumbnail

Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

TechCrunch

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Neuroglee gets $2.3

article thumbnail

[Eko Health in PR Newswire] Astellas and Eko Health announce agreement to incorporate next generation Eko CORE 500™ Digital Stethoscope into Z1608, an innovative solution under development for heart failure patients built on Welldoc’s proven digital therapeutic platform

OurCrowd

The post [Eko Health in PR Newswire] Astellas and Eko Health announce agreement to incorporate next generation Eko CORE 500™ Digital Stethoscope into Z1608, an innovative solution under development for heart failure patients built on Welldoc’s proven digital therapeutic platform appeared first on OurCrowd Blog.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Neuroglee gets $2.3 million to develop digital therapeutics for neurodegenerative diseases

TechCrunch

Neuroglee , a Singapore-based health tech startup, wants to help with a digital therapeutic platform created to treat patients in the early stages of the disease. SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis. million in pre-seed funding. The round was led by Eisai Co.,

article thumbnail

The growing power of digital healthcare: 6 trends to watch in 2022

TechCrunch

Digital therapeutics will rewrite the future of healthcare. Digital therapeutics is perhaps the most innovative development in healthcare today and has the potential to dramatically change how care is delivered.

article thumbnail

6 questions investors should ask when evaluating psychedelic biotech companies

TechCrunch

As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. Greg Kubin is a partner at PsyMed Ventures and co-host of Business Trip.

article thumbnail

[DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D

OurCrowd

David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap. Read more here.

article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. in funding.

health 113